Anne-Claude Tabet

Anne-Claude Tabet

Auto-generated profile, based on publicly available information

Anne-Claude Tabet

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2017 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
ATAnne-Claude Tabet
Anne-Claude Tabet
TRThomas Rolland
Thomas Rolland
MDMarie Ducloy
Marie Ducloy
JLJonathan Levy
Jonathan Levy
JBJulien Buratti
Julien Buratti
TBThomas Bourgeron
Thomas Bourgeron
Phelan-McDermid syndrome (PMS) is characterized by a variety of clinical symptoms with heterogeneous degrees of severity, including intellectual disability (ID), absent or delayed speech, and autism spectrum disorders (ASD). It results from a deletion of the distal part of chromosome 22q13 that in most cases includes the SHANK3 gene. SHANK3 is considered a major gene for PMS, but the factors that modulate the severity of the syndrome remain largely unknown. In this study, we investigated 85 patients with different 22q13 rearrangements (78 deletions and 7 duplications). We first explored the clinical features associated with PMS, and provide evidence for frequent corpus callosum abnormalities in 28% of 35 patients with brain imaging data. We then mapped several candidate genomic regions at the 22q13 region associated with high risk of clinical features, and suggest a second locus at 22q13 associated with absence of speech. Finally, in some cases, we identified additional clinically relevant copy-number variants (CNVs) at loci associated with ASD, such as 16p11.2 and 15q11q13, which could modulate the severity of the syndrome. We also report an inherited SHANK3 deletion transmitted to five affected daughters by a mother without ID nor ASD, suggesting that some individuals could compensate for such mutations. In summary, we shed light on the genotype-phenotype relationship of patients with PMS, a step towards the identification of compensatory mechanisms for a better prognosis and possibly treatments of patients with neurodevelopmental disorders.

15 March 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
TLThuy-Linh Le
Thuy-Linh Le
LGLouise Galmiche
Louise Galmiche
JLJonathan Levy
Jonathan Levy
PSPim Suwannarat
Pim Suwannarat
DHDebby M.E.I. Hellebrekers
Debby M.E.I. Hellebrekers
NBNadege Bondurand
Nadege Bondurand
Hirschsprung disease (HSCR) is the most frequent developmental anomaly of the enteric nervous system, with an incidence of 1 in 5000 live births. Chronic intestinal pseudo-obstruction (CIPO) is less frequent and classified as neurogenic or myogenic. Isolated HSCR has an oligogenic inheritance with RET as the major disease-causing gene, while CIPO is genetically heterogeneous, caused by mutations in smooth muscle–specific genes. Here, we describe a series of patients with developmental disorders including gastrointestinal dysmotility, and investigate the underlying molecular bases. Trio-exome sequencing led to the identification of biallelic variants in ERBB3 and ERBB2 in 8 individuals variably associating HSCR, CIPO, peripheral neuropathy, and arthrogryposis. Thorough gut histology revealed aganglionosis, hypoganglionosis, and intestinal smooth muscle abnormalities. The cell type–specific ErbB3 and ErbB2 function was further analyzed in mouse single-cell RNA sequencing data and in a conditional ErbB3-deficient mouse model, revealing a primary role for ERBB3 in enteric progenitors. The consequences of the identified variants were evaluated using quantitative real-time PCR (RT-qPCR) on patient-derived fibroblasts or immunoblot assays on Neuro-2a cells overexpressing WT or mutant proteins, revealing either decreased expression or altered phosphorylation of the mutant receptors. Our results demonstrate that dysregulation of ERBB3 or ERBB2 leads to a broad spectrum of developmental anomalies, including intestinal dysmotility.

16 May 2018 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
JLJonathan Levy
Jonathan Levy
SGS. Grotto
S. Grotto
CMC. Mignot
C. Mignot
AMA. Maruani
A. Maruani
ADAndrée Delahaye-Duriez
Andrée Delahaye-Duriez
ATA.‐C. Tabet
A.‐C. Tabet

15 March 2018 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
JLJonathan Levy
Jonathan Levy
DHD. Haye
D. Haye
NMN. Marziliano
N. Marziliano
Gavino CasuGavino Casu
Gavino Casu
FGF. Guimiot
F. Guimiot
ATA.‐C. Tabet
A.‐C. Tabet

27 April 2020 in Genes
Verified
Journal Article
Open access
PDF file
Radhia M'kacherRadhia M'kacher
Radhia M'kacher
BCBruno Colicchio
Bruno Colicchio
CBClaire Borie
Claire Borie
Steffen JunkerSteffen Junker
Steffen Junker
VMValentine Marquet
Valentine Marquet
Eric JEANDIDIEREric JEANDIDIER
Eric JEANDIDIER
Dicentric chromosomes are a relevant marker of chromosomal instability. Their appearance is associated with telomere dysfunction, leading to cancer progression and a poor clinical outcome. Here, we present Telomere and Centromere staining followed by M-FISH (TC+M-FISH) for improved detection of telomere dysfunction and the identification of dicentric chromosomes in cancer patients and various genetic syndromes. Significant telomere length shortening and significantly higher frequencies of telomere loss and deletion were found in the peripheral lymphocytes of patients with cancer and genetic syndromes relative to similar age-matched healthy donors. We assessed our technique against conventional cytogenetics for the detection of dicentric chromosomes by subjecting metaphase preparations to both approaches. We identified dicentric chromosomes in 28/50 cancer patients and 21/44 genetic syndrome patients using our approach, but only 7/50 and 12/44, respectively, using standard cytogenetics. We ascribe this discrepancy to the identification of the unique configuration of dicentric chromosomes. We observed significantly higher frequencies of telomere loss and deletion in patients with dicentric chromosomes (p < 10−4). TC+M-FISH analysis is superior to classical cytogenetics for the detection of chromosomal instability. Our approach is a relatively simple but useful tool for documenting telomere dysfunction and chromosomal instability with the potential to become a standard additional diagnostic tool in medical genetics and the clinic.

5 February 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
JLJonathan Levy
Jonathan Levy
YCYline Capri
Yline Capri
MRMyriam Rachid
Myriam Rachid
CDCéline Dupont
Céline Dupont
JVJoris Robert Vermeesch
Joris Robert Vermeesch
IBIsabelle Bailleul‐Forestier
Isabelle Bailleul‐Forestier